Decision/Conclude agreement
Proposed
泰格醫藥擬收購方達控股中國內地非目標業務
Tigermed plans to acquire the mainland China non-target business of Frontage Holdings after its privatization, a move that could help Tigermed focus on core clinical CRO services while divesting non-core operations.
Trajectories
Sign-in readers can mine up to three arcs for this record.
Actors and targets
Source
私有化完成後,泰格醫藥擬收購中國內地非目標業務,初步估值約2.055億美元
Extracted detail
Related decisions
Same kind only, ranked by embedding similarity to this record.